Oxford Biodynamics Plc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Oxford Biodynamics Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10695
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Oxford Biodynamics Plc (Oxford Biodynamics) is a developer of biomarker discovery platform. The company concentrates on research in detection, monitoring and prognosis of major diseases associated with aberrant gene expression such as oncology, metabolic, inflammatory, cardiovascular and neurodegenerative conditions. Its biomarker discovery platform is used for the detection of aberrant gene expression. The company’s products are used in the areas of breast cancer diagnostics, hepatocellular carcinoma diagnostics, nasopharyngeal carcinoma diagnostics, prostate cancer progression, melanoma diagnostics, and age related disease diagnostics. Oxford Bio is headquartered in Oxford, Oxfordshire, the UK.

Oxford Biodynamics Plc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Oxford Biodynamics Plc, Medical Devices Deals, 2012 to YTD 2018 9
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
GL Capital Invests USD12.5 Million in Oxford BioDynamics 11
Partnerships 13
Oxford BioDynamics Enters into Agreement with US Biopharma Company for Biomarkers 13
Oxford BioDynamics Enters into Agreement with US Biopharma Company 14
Oxford Biodynamics Enters into Development Agreement with Two Pharmaceutical Companies 15
Equity Offering 16
Oxford BioDynamics Raises USD24.9 Million in Issue of New Ordinary Shares 16
Oxford Biodynamics Plc – Key Competitors 17
Oxford Biodynamics Plc – Key Employees 18
Oxford Biodynamics Plc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
May 22, 2018: Oxford Biodynamics: Interim Results For The Six-Month Period Ended 31 March 2018 20
Jan 30, 2018: Oxford BioDynamics Reports Revenue of £1.2m For The Year Ended 30 September 2017 21
Jun 13, 2017: Oxford Biodynamics Interim Results For The Six-Month Period Ended 31 March 2017 22
Jan 31, 2017: Oxford BioDynamics Announces Final Results for the Year Ended 30 September 2016 27
Corporate Communications 29
Sep 15, 2017: Oxford BioDynamics appoints Paul Stockdale as Chief Financial Officer and Executive Director on the Board 29
Jun 30, 2017: Oxford BioDynamics: Appointment of Paul Stockdale as Chief Financial Officer 30
Mar 09, 2017: Oxford BioDynamics announces appointment of Martin Reeves as Senior Vice President of Commercial Development 31
Feb 13, 2017: Oxford BioDynamics appoints Dr Claudio Carini as an Advisor 32
Government and Public Interest 33
Sep 18, 2018: Consortium including Oxford BioDynamics receives €4 million Horizon 2020 award 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Key Facts 2
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oxford Biodynamics Plc, Deals By Therapy Area, 2012 to YTD 2018 8
Oxford Biodynamics Plc, Medical Devices Deals, 2012 to YTD 2018 9
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
GL Capital Invests USD12.5 Million in Oxford BioDynamics 11
Oxford BioDynamics Enters into Agreement with US Biopharma Company for Biomarkers 13
Oxford BioDynamics Enters into Agreement with US Biopharma Company 14
Oxford Biodynamics Enters into Development Agreement with Two Pharmaceutical Companies 15
Oxford BioDynamics Raises USD24.9 Million in Issue of New Ordinary Shares 16
Oxford Biodynamics Plc, Key Competitors 17
Oxford Biodynamics Plc, Key Employees 18
Oxford Biodynamics Plc, Other Locations 19

List of Figures
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Oxford Biodynamics Plc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Oxford Biodynamics Plc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nationwide Financial Services, Inc.:企業の戦略的SWOT分析
    Nationwide Financial Services, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Aldevron LLC-製薬・医療分野:企業M&A・提携分析
    Summary Aldevron LLC (Aldevron) is a custom manufacturing and development service provider. The company manufactures plasmid deoxyribonucleic acid for research, preclinical and clinical applications. It offers nucleic acid, protein, and antibody services. Aldevron's protein production services inclu …
  • Hemisphere Energy Corp (HME):石油・ガス:M&Aディール及び事業提携情報
    Summary Hemisphere Energy Corp (Hemisphere), formerly Northern Hemisphere Development Corp is an oil and gas company that offers development of oil production reserves. The company offers strategic acquisitions and farm-ins that provide low-risk drilling opportunities. Its operations include heavy o …
  • Grupa Azoty Zaklady Chemiczne Police SA (PCE):企業の財務・戦略的SWOT分析
    Grupa Azoty Zaklady Chemiczne Police SA (PCE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Blockchain Power Trust (TEP.UN):電力:M&Aディール及び事業提携情報
    Summary Blockchain Power Trust is an alternative energy company that offers power solutions. The company's services include wind energy solutions, power generations, transmission, supplying, and distribution services. It also provides solar energy solutions, and hydropower energy solutions, among ot …
  • Bioxyne Ltd (BXN):企業の財務・戦略的SWOT分析
    Bioxyne Ltd (BXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • ANS Group Plc:企業の戦略的SWOT分析
    ANS Group Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • SK Holdings Co Ltd (034730):企業の財務・戦略的SWOT分析
    SK Holdings Co Ltd (034730) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Naim Holdings Berhad:企業の戦略・SWOT・財務情報
    Naim Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary Naim Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Fibrocell Science Inc (FCSC):医療機器:M&Aディール及び事業提携情報
    Summary Fibrocell Science Inc (Fibrocell Science) is an autologous cell and gene therapy company which discovers and develops therapies for diseases affecting the skin and connective tissue. The company’s product pipeline comprises FCX-007, a lead candidate for the treatment of recessive dystrophic …
  • Lexicon Pharmaceuticals Inc (LXRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Lexicon Pharmaceuticals Inc (Lexicon) is a biopharmaceutical company, which focuses on the discovery, development and commercialization of innovative treatments for human diseases. The company has advanced multiple drug candidates into clinical development and has clinical-stage drug program …
  • Abivax SA (ABVX):企業の財務・戦略的SWOT分析
    Summary Abivax SA (Abivax) operates as a biotechnology company. It develops and commercializes anti-viral therapies and therapeutic vaccines for the treatment of infectious and viral diseases. The company’s pipeline products include ABX464, ABX544 and ABX196. Its ABX464 is an oral small molecule to …
  • ITM Power Plc (ITM):企業の財務・戦略的SWOT分析
    ITM Power Plc (ITM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Taewoong Medical Co Ltd:企業の製品パイプライン分析2018
    Summary Taewoong Medical Co Ltd (Taewoong Medical) is a medical device company that develops and manufactures stents and other medical devices. The company offers products such as self-expandable metal stent, endoscopic RFA, endoscopic accessory, ureteral stent, airway stent, colonic stent, surgical …
  • Maersk Tankers AS:石油・ガス:M&Aディール及び事業提携情報
    Summary Maersk Tankers AS (Maersk Tankers), a subsidiary of A.P. Moeller Holding AS is an oil and gas company that offers energy transportation services through oil tankers. The company provides services such as crude oil and refined oil transportation, warehousing and distribution, supply chain man …
  • Pioneer Natural Resources Co (PXD)-石油・ガス分野:企業M&A・提携分析
    Summary Pioneer Natural Resources Company (Pioneer) is an independent oil and natural gas exploration and production company. Its principally operates in Eagle Ford Shale, Permian Basin, Raton Basin, and West Panhandle. In Permian Basin, the company carries out its exploration and production activit …
  • Texas Children’s Hospital:企業の戦略的SWOT分析
    Texas Children's Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Universal Display Corp (OLED):企業の財務・戦略的SWOT分析
    Summary Universal Display Corp (UDC) is a clean technology company that conducts research, develops and markets organic light emitting diode, technologies and materials. The company offers PHOLED materials which are used in making OLED displays and lighting panels. It provides technologies such as F …
  • China Construction Bank Corp:企業の戦略・SWOT・財務分析
    China Construction Bank Corp - Strategy, SWOT and Corporate Finance Report Summary China Construction Bank Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Siemens Healthcare GmbH (SHL):医療機器:M&Aディール及び事業提携情報
    Summary Siemens Healthcare GmbH (Siemens Healthineers), a subsidiary of Siemens AG, is a global medical device company that designs, develops, manufactures and distributes medical devices and technologies for diagnostic markets. Its major products include healthcare IT, laboratory diagnostics equipm …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆